Chancery Holding Amplifies Approach To Boardroom Issues

By Gail Weinstein, Steven Steinman and Brian Mangino (July 21, 2022, 5:35 PM EDT) -- In the recent Goldstein v. Denner decision, the Delaware Chancery Court held, at the pleading stage of litigation, that the directors and certain officers of Bioverativ Inc. — which had recently been spun off from Biogen Inc. — may have breached their fiduciary duties in connection with the $11.6 billion sale of Bioverativ to Sanofi SA....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as